The Expression of Matrix Metalloproteinase (MMP-2) in Gestational Trophoblastic Disease (GTD)

WANG Li-juan,ZONG Lu,YANG Xiao-feng
DOI: https://doi.org/10.3969/j.issn.1672-4992.2006.08.036
2006-01-01
Journal of Modern Oncology
Abstract:Objective:To investigate the expression and detecte the significance of matrix metalloproteinase(MMP-2) in normal villi and gestational trophoblastic disease(GTD).Methods: Using immunohistochemical S-P method to detect the expression of MMP-2 in 10 cases normal villi,hydatiform mole 20 cases,invasive mole 32 cases and choriocarcinoma 16 cases respectively.Results: MMP-2 mainly expressed in syncytio-and extrovillous trophoblast.The expression of MMP-2 could be detected in both of normal villi and GTD tissues,but the positive ratio of expression was higher in GTD(P0.05),the expression intensity was different significantly between normal villi and early trimester hydatiform mole(P0.05),the expression rate was not related to hydatiform mole pathological type and gestational sequence.The positive ratio of MMP-2 was significantly higher in first trimster than in second or third trimester hydatiform mole.There was no any association between the expression of MMP-2 and clinical stage for invasive mole or choriocarcinoma.The positive ratio of MMP-2 was significantly higher in invasive mole cases treated without chemotherapy than the cases with chmeotherapy(P0.05),and it was higher in choriocarinoma cases with chemotherapy than without chemotherapy,but there was no significantly difference.Conclusion: The expression of MMP-2 was positively related to the invasive activity of trophoblast cell,and negatively related to the gestational weeks,this phenomena might be associated with time-space phase character and life longevity of normal villi's invasiveness.The expression of MMP-2 become more and more intensively with the advance progress of GTD,the intensity of expression is decreased dramatically after chemotherapy,it was demonstrated that MMP-2 could be as an important diagnostic and prognostic marker for GTD treatment.
What problem does this paper attempt to address?